Cuba’s Health Ministry says its three-shot Abdala vaccine showed over 92% efficacy against COVID-19 in a late-stage clinical trial. The announcement came days after promising initial results from another Cuban vaccine candidate, Soberana 02.
Topics:
Cuba’s Health Ministry says its three-shot Abdala vaccine showed over 92% efficacy against COVID-19 in a late-stage clinical trial. The announcement came days after promising initial results from another Cuban vaccine candidate, Soberana 02.